EMMUNE INC
US UEI N65ZDYUGWAH8 · SME
20public awards
$22.0Mtotal public funding
2026-07-24latest award
State aid awards (20)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-07-24 | $299k | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2026-03-02 | $300k | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2025-12-11 | $917k | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2025-09-23 | $1,000k | Grant | Process development for manufacturing eCD4-Ig | Department of Health and Human Services |
| 2025-05-09 | $300k | Grant | IND-enabling studies for eCD4-Ig as a long-acting recombinant protein | Department of Health and Human Services |
| 2023-08-17 | $3.0M | Grant | SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites | Department of Health and Human Services |
| 2023-01-01 | $300k | Grant | Process development for manufacturing eCD4-Ig | Department of Health and Human Services |
| 2022-08-08 | $300k | Grant | SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites | Department of Health and Human Services |
| 2022-03-09 | $2.9M | Grant | Glycoengineering eCD4-Ig | Department of Health and Human Services |
| 2022-03-01 | $2.0M | Grant | Engineering AAV capsids for enhanced transduction of skeletal muscle | Department of Health and Human Services |
| 2021-07-14 | $300k | Grant | Glycoengineering eCD4-Ig | Department of Health and Human Services |
| 2020-09-01 | $325k | Grant | Engineering AAV capsids for enhanced transduction of skeletal muscle | Department of Health and Human Services |
| 2020-05-19 | $2.7M | Grant | Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig | Department of Health and Human Services |
| 2019-08-01 | $300k | Grant | Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig | Department of Health and Human Services |
| 2018-08-27 | $3.0M | Grant | Development of AAV vectors for long-term expression of eCD4-Ig | Department of Health and Human Services |
| 2018-01-15 | $300k | Grant | Cpf1-mediated inactivation of an AAV transgene | Department of Health and Human Services |
| 2017-08-01 | $299k | Grant | Development of AAV vectors for long term expression of eCD Ig | Department of Health and Human Services |
| 2017-02-09 | $1.9M | Grant | WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICATION | Department of Health and Human Services |
| 2016-06-10 | $1.2M | Grant | WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICATION | Department of Health and Human Services |
| 2015-06-15 | $224k | Grant | Development of a synthetic antibody based on the HIV receptor and co-r | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →